Fetuin-B is a relatively understudied hepatokine associated with insulin resistance, dyslipidemia, and non-alcoholic fatty liver disease (Meex and Watt, 2017; Mokou et al., 2020; Olkowicz et al., 2021). This evidence concerns the gene FETUB and metabolic dysfunction-associated steatotic liver disease.